Team Novo Nordisk returns to Philadelphia Cycling Classic for awareness campaign
Yahoo Sports • 1 min read • Latest: Aug 27, 2026, 10:00 PM
Last updated Aug 27, 2026

Team Novo Nordisk will participate in the Philadelphia Cycling Classic on August 30, 2026. Comprised of cyclists living with Type 1 diabetes, the team aims to inspire others with the condition. David Lozano, a team member, shares his journey and the importance of overcoming challenges. The event features women's and men's races and will include outreach efforts, including a tent for children with diabetes to meet the riders.
- •Philadelphia Cycling Classic returns after a decade-long hiatus.
- •Team Novo Nordisk aims to inspire those living with diabetes.
- •David Lozano emphasizes overcoming personal challenges.
- •Children with Type 1 diabetes will meet the team at the race.
- •The event includes both women's and men's racing categories.
- 10:00 PMYahoo Sports — Team Novo Nordisk returns to Philadelphia Cycling Classic with message of perseverance
"The Philadelphia Cycling Classic is welcoming back Team Novo Nordisk, a professional cycling team whose riders all compete while living with Type 1 diabetes.
Sources
External linksOriginal reporting and copyright belong to the linked sources. SportsNewsReport.com aggregates and links — it does not republish full articles.
Related Stories
Last 14 days
IPL•Oct 14, 2026, 3:03 PMGautam Gambhir turns 45: 'A fighter on the field' - special birthday wishes pour in- IPL•Oct 14, 2026, 3:01 PMGB men 'on back foot' after Richardson withdrawal, but women take silver
IPL•Oct 11, 2026, 3:46 PM'No surprise': New Zealand ready for 'unreal talent' Vaibhav Sooryavanshi ahead of T20I series
IPL•Oct 10, 2026, 4:00 PM'Doesn’t make sense': Dinesh Karthik on scrapping Impact Player rule before IPL 2027
IPL•Oct 10, 2026, 3:31 PMPaul Seixas announces arrival with Il Lombardia triumph after riders stage protest over safety
IPL•Oct 10, 2026, 11:16 AMRiders stage safety protest before Giro di Lombardia: ‘We will not stand for this’
